Less than a year after approval, Pfizer said it plans to discontinue its hemophilia B gene therapy fidanacogene elaparvovec ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

TEPEZZA, as the first FDA-approved treatment for thyroid eye disease, marks a major breakthrough in managing TED, addressing a critical medical gap for patients who have long had few treatment ...

IgG1 antibodies reached ... and fine tailoring of antibody structures to bring new antibodies to the market. Following the success of the first generation of monoclonal antibody blockbusters ...

Due to their extraordinary specificity and pharmacokinetic (PK) behavior, human immunoglobulin gamma monoclonal antibodies ... genetically engineered human IgG1 antibodies in a humanized FcRn ...

View Full Profile. Learn about our Editorial Policies. Scientists create monoclonal antibodies by cloning a single antibody-producing cell line. In contrast to polyclonal antibodies, monoclonals are ...

The Antibody and Bioresource Core Facility supports researchers by making it easier for them to develop new monoclonal antibodies (MAbs). This is accomplished by being an informational resource as ...